We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
(+13%)
Cap. Flow
+$8.49M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.25M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.25M |
| 3 |
Haemonetics
HAE
|
+$779K |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$759K |
| 5 |
GoDaddy
GDDY
|
+$694K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$858K |
| 2 |
DXC Technology
DXC
|
+$821K |
| 3 |
West Pharmaceutical
WST
|
+$728K |
| 4 |
Southwest Airlines
LUV
|
+$717K |
| 5 |
Howmet Aerospace
HWM
|
+$650K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.52% |
| 2 | Industrials | 13.79% |
| 3 | Consumer Discretionary | 12.99% |
| 4 | Healthcare | 11.5% |
| 5 | Financials | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Huntington Bancshares
HBAN
$35.1B
| $234K | 0.19% |
+15,536
| New | +$228K |
|
277
Check Point Software Technologies
CHKP
$13.3B
| $233K | 0.19% |
+2,104
| New | +$236K |
|
278
Ingevity
NGVT
$2.55B
| $233K | 0.19% |
2,661
-2,671
| -50% | -$234K |
|
|
FSCT
279
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $233K | 0.19% |
+7,101
| New | +$233K |
|
280
Hexcel
HXL
$8.32B
| $232K | 0.19% |
+3,160
| New | +$243K |
|
281
Magna International
MGA
$17.9B
| $232K | 0.19% |
+4,227
| New | +$229K |
|
282
New Jersey Resources
NJR
$6.06B
| $232K | 0.19% |
+5,198
| New | +$225K |
|
|
HRC
283
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $232K | 0.19% |
2,047
-338
| -14% | -$35.6K |
|
|
NSA
284
DELISTED
National Storage Affiliates Trust
NSA
| $231K | 0.19% |
+6,881
| New | +$231K |
|
285
Ametek
AME
$55.5B
| $230K | 0.19% |
+2,309
| New | +$219K |
|
|
EVBG
286
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $230K | 0.19% |
+2,949
| New | +$228K |
|
287
Arcosa
ACA
$7.12B
| $229K | 0.18% |
+5,147
| New | +$198K |
|
288
First American
FAF
$7.67B
| $229K | 0.18% |
3,935
-1,903
| -33% | -$116K |
|
289
Vertex Pharmaceuticals
VRTX
$121B
| $229K | 0.18% |
+1,044
| New | +$211K |
|
290
Coca-Cola Europacific Partners
CCEP
$46.5B
| $228K | 0.18% |
+4,474
| New | +$236K |
|
291
Best Buy
BBY
$18B
| $227K | 0.18% |
2,587
-4,774
| -65% | -$365K |
|
292
Taylor Morrison
TMHC
| $227K | 0.18% |
10,400
+1,907
| +22% | +$45.8K |
|
293
Toro Company
TTC
$8.93B
| $225K | 0.18% |
+2,822
| New | +$216K |
|
|
EB
294
DELISTED
Eventbrite
EB
| $224K | 0.18% |
+11,130
| New | +$213K |
|
295
Sprouts Farmers Market
SFM
$7.04B
| $223K | 0.18% |
+11,547
| New | +$224K |
|
296
Sociedad Química y Minera de Chile
SQM
$19.6B
| $223K | 0.18% |
+8,357
| New | +$220K |
|
297
Okta
OKTA
$24.1B
| $222K | 0.18% |
+1,925
| New | +$222K |
|
298
Perdoceo Education
PRDO
$1.9B
| $222K | 0.18% |
+12,068
| New | +$196K |
|
299
American Eagle Outfitters
AEO
$2.85B
| $221K | 0.18% |
15,067
-14,253
| -49% | -$218K |
|
300
Commault Systems
CVLT
$5.89B
| $221K | 0.18% |
+4,946
| New | +$234K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.
- Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
- Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
- Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
- Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
- Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
- Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
- Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.
Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.